XRF Stock Overview

Manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. More details

XRF fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	2/6
Past Performance	4/6
Financial Health	6/6
Dividends	3/6

Rewards

Trading at 18.1% below our estimate of its fair value

Earnings are forecast to grow 11.83% per year

Earnings grew by 15.6% over the past year

Risk Analysis

XRF passed our risk checks.

My Notes

Capture your thoughts, links and company narrative

XRF Scientific Limited Competitors

VEEM

ASX:VEE

AU$168.4m

Environmental Group

ASX:EGL

AU$119.9m

Korvest

ASX:KOV

AU$120.4m

LaserBond

ASX:LBL

AU$64.5m

Price History & Performance

Summary of share price highs, lows and changes for XRF Scientific
Historical stock prices
Current Share Price	AU$1.81
52 Week High	AU$1.93
52 Week Low	AU$1.02
Beta	0.94
1 Month Change	13.17%
3 Month Change	21.14%
1 Year Change	58.33%
3 Year Change	211.21%
5 Year Change	668.09%
Change since IPO	684.78%

Recent updates

Shareholder Returns

	XRF	AU Machinery	AU Market
7D	2.0%	-9.0%	-2.7%
1Y	58.3%	16.3%	6.5%

Return vs Industry: XRF exceeded the Australian Machinery industry which returned 16.2% over the past year.

Return vs Market: XRF exceeded the Australian Market which returned 6.5% over the past year.

Price Volatility

Is XRF's price volatile compared to industry and market?
XRF volatility
XRF Average Weekly Movement	4.7%
Machinery Industry Average Movement	7.6%
Market Average Movement	8.0%
10% most volatile stocks in AU Market	16.8%
10% least volatile stocks in AU Market	3.1%

Stable Share Price: XRF has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: XRF's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1972	n/a	Vance Stazzonelli	www.xrfscientific.com

XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. The company operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures automated fusion equipment, high temperature test, production furnaces, and laboratory jaw crushers, as well as general laboratory equipment.

XRF Scientific Limited Fundamentals Summary

How do XRF Scientific's earnings and revenue compare to its market cap?
XRF fundamental statistics
Market cap	AU$252.89m
Earnings (TTM)	AU$8.89m
Revenue (TTM)	AU$60.12m

28.5x

P/E Ratio

4.2x

P/S Ratio

Is XRF overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XRF income statement (TTM)
Revenue	AU$60.12m
Cost of Revenue	AU$33.57m
Gross Profit	AU$26.55m
Other Expenses	AU$17.66m
Earnings	AU$8.89m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.063
Gross Margin	44.16%
Net Profit Margin	14.78%
Debt/Equity Ratio	5.3%

How did XRF perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

60%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 03:46
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

XRF Scientific Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Cameron Bell	Canaccord Genuity

XRF Stock Overview

Rewards

Risk Analysis

XRF Scientific Limited Competitors

ASX:VEE

AU$168.4m

ASX:EGL

AU$119.9m

ASX:KOV

AU$120.4m

ASX:LBL

AU$64.5m

Price History & Performance

Recent News & Updates

XRF Scientific Limited (ASX:XRF) agreed to acquire Labfit Pty Ltd for AUD 1.5 million.

Now 20% undervalued

XRF Scientific Limited, Annual General Meeting, Oct 21, 2024

New minor risk - Dividend sustainability

Upcoming dividend of AU$0.039 per share

XRF Scientific Limited Announces Ordinary Full Franked Dividend for the Twelve Months Ended June 30, 2024, Payment Date of September 27, 2024

Recent updates

XRF Scientific Limited (ASX:XRF) agreed to acquire Labfit Pty Ltd for AUD 1.5 million.

Now 20% undervalued

XRF Scientific Limited, Annual General Meeting, Oct 21, 2024

New minor risk - Dividend sustainability

Upcoming dividend of AU$0.039 per share

XRF Scientific Limited Announces Ordinary Full Franked Dividend for the Twelve Months Ended June 30, 2024, Payment Date of September 27, 2024

Full year 2024 earnings released: EPS: AU$0.064 (vs AU$0.056 in FY 2023)

Now 20% undervalued

XRF Scientific Limited (ASX:XRF) completed the acquisition of remaining 50% stake in Orbis Mining Pty. Ltd. for AUD 3.8 million.

XRF Scientific Limited to Report Fiscal Year 2024 Results on Aug 20, 2024

Now 23% undervalued

Now 22% undervalued

Now 20% undervalued

Now 21% undervalued

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023)

New minor risk - Market cap size

XRF Scientific Limited, Annual General Meeting, Oct 31, 2023

Upcoming dividend of AU$0.033 per share at 3.0% yield

New minor risk - Dividend sustainability

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.045 in FY 2022)

XRF Scientific Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2023, Payment Date of October 13, 2023

Now 24% undervalued

Non-Executive Director recently bought AU$89k worth of stock

New minor risk - Market cap size

Investor sentiment improves as stock rises 16%

Non-Executive Director recently bought AU$61k worth of stock

Investor sentiment improves as stock rises 16%

Now 21% undervalued

Now 23% undervalued

First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022)

Insufficient new directors

Now 21% undervalued

XRF Scientific Limited Announces Dividend That Relates to the Financial Reporting or Payment Period Ended on June 30, 2022, Payable on October 14, 2022

Upcoming dividend of AU$0.025 per share

XRF Scientific Limited, Annual General Meeting, Oct 21, 2022

Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021)

XRF Scientific Limited Announces Fully Franked Ordinary Dividend for the Year Ended June 30, 2022, Payable on 14 October 2022

Now 20% undervalued

Now 24% undervalued

Insufficient new directors

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Insufficient new directors

Upcoming dividend of AU$0.02 per share

Full year 2021 earnings released: EPS AU$0.038 (vs AU$0.023 in FY 2020)

Non-Executive Director recently bought AU$72k worth of stock

New 90-day low: AU$0.28

Non-Executive Director recently bought AU$93k worth of stock

First half 2021 earnings released: EPS AU$0.018 (vs AU$0.012 in 1H 2020)

New 90-day low: AU$0.28

New 90-day high: AU$0.33

Upcoming Dividend of AU$0.014 Per Share

Earnings released

New 90-day high - AU$0.29

Shareholder Returns

Price Volatility

About the Company

XRF Scientific Limited Fundamentals Summary

28.5x

4.2x